Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Nov 9, 2015, after the close
10-Q filed Nov 9, 2015, 40 days after period end · 0001144204-15-063721
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $2.50K | $5.00K | $2.50K | $170.83K |
| Net Income | -$5.64M | -$4.46M | -$6.69M | -$2.58M |
| EPS Diluted | -$0.06 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.05 |
| -$0.09 |
| -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
